Table of Contents Author Guidelines Submit a Manuscript

About this Journal

An exciting journal in the area of contrast agents and molecular imaging, covering all areas of imaging technologies with a special emphasis on MRI and PET.

Contrast Media & Molecular Imaging (CMMI) provides an international forum for the expeditious publication of research articles, reviews, clinical studies, and letters to the editors in the booming areas of contrast media and molecular imaging. CMMI is aimed at the academic, medical, and industrial communities, and at the developers and users of these emerging and rapidly developing technologies in the areas of MRI and MRS, but also embracing all other in vivo imaging technologies such as PET, photon-counting CT, spectral photon-counting CT, and ultrasound contrast agents.

Molecular imaging articles will concentrate on the potential role played by MRI and PET contrast agents at visualizing, at the molecular or cellular level, the physiology and physio-pathological processes from animal models to humans.

CMMI articles will cover innovative work on all aspects of this field, such as the development of more specific or sensitive agents, agents directed toward new targets, comparison of MRI with other imaging modalities, and prompting of multi-modality approaches.

CMMI will devote particular attention to the following fields: synthesis, characterization, and biological applications of new contrast agents, search for new vectors and ligands, coupling strategies, and in vitro as well in vivo evaluation of new methodologies and applications.

Contrast Media & Molecular Imaging is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. For more information on Article Processing charges in general, click here.

Contrast Media & Molecular Imaging is included in many leading abstracting and indexing databases. For a complete list, click here.

The most recent Impact Factor for Contrast Media & Molecular Imaging is 1.984 according to the 2018 Journal Citation Reports released by Clarivate Analytics in 2019. The journal’s most recent CiteScore is 2.44 according to the CiteScore 2018 metrics released by Scopus.

Content published prior to 2017 is hosted on the Wiley Online Library.

60%
Acceptance
98 days
Final Decision
44 days
Publication
$1600
APC

Featured Articles

Open Special Issues

The Wiley Hindawi Partnership

This journal is published by Hindawi as part of a publishing collaboration with John Wiley & Sons, Inc. It is a fully Open Access journal produced under the Hindawi and Wiley brands. For more information please click here.